|
|
||||||||||||||
|
|
|||||||||||||||
EDITORIAL |
| Potential reduced exposure products |
Correspondence to:
Thomas Eissenberg
Virginia Commonwealth University, Richmond, VA 23298, USA; teissenb@vcu.edu
Keywords: tobacco; potential reduced exposure products; evaluation
| The first 150 words of the full text of this article appear below. |
Potential reduced exposure products (PREPs) for smokers are marketed by the tobacco industry as a way for smokers to reduce toxicant intake while continuing to use tobacco.1 In the past, similarly marketed products, so called "low yield" cigarettes, were financial successes but public health failures.1,2 Deceptive marketing of these early PREPs helps to explain their financial success,3 while a lack of objective pre-market evaluation of users smoke toxicant exposure helps to explain their public health failure.1,4 Given this history, anyone interested in public health is correct to be sceptical of the marketing that surrounds a new generation of PREPs in the USA (for example, Accord®, AdvanceTM, Aeros®, Eclipse®, Quest®) and Europe (for example, NicStic®). Even more important, public health advocates are correct to insist that PREPs be evaluated comprehensively, rigorously, and objectively.1,5 This type of evaluation will help ensure that
This article has been cited by other articles:
![]() |
G. E. Matt, J. T. Bernert, and M. F. Hovell Measuring Secondhand Smoke Exposure in Children: An Ecological Measurement Approach J. Pediatr. Psychol., March 1, 2008; 33(2): 156 - 175. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |